YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

A Case of Levetiracetam Induced Bullous Pemphigoid

dc.authorscopusid 26425048800
dc.authorscopusid 17134049200
dc.authorscopusid 8941649100
dc.authorscopusid 55489703200
dc.authorscopusid 6603721364
dc.authorscopusid 6504393989
dc.authorwosid Karadag, Ayse/V-7974-2018
dc.authorwosid Kösem, Mustafa/Jce-7269-2023
dc.contributor.author Karadag, Ayse Serap
dc.contributor.author Bilgili, Serap Gunes
dc.contributor.author Calka, Omer
dc.contributor.author Onder, Sevda
dc.contributor.author Kosem, Mustafa
dc.contributor.author Burakgazi-Dalkilic, Evren
dc.date.accessioned 2025-05-10T17:44:13Z
dc.date.available 2025-05-10T17:44:13Z
dc.date.issued 2013
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Karadag, Ayse Serap; Bilgili, Serap Gunes; Calka, Omer; Onder, Sevda] Yuzuncu Yil Univ, Sch Med, Dept Dermatol, Van, Turkey; [Burakgazi-Dalkilic, Evren] UMDNJ Cooper Univ Med Ctr, Piscataway, NJ USA en_US
dc.description.abstract Bullous pemphigoid is a chronic, acquired autoimmune skin disease. Certain drugs such as furosemide, penicillins, sulfonamides, ciprofloxacins, penicillamines, angiotensin converting enzyme inhibitors, chloroquine, and phenacetin were reported to cause bullous pemphigoid. This is a case report of a 70-year-old female, who presented with the formation of diffuse cutaneous blister in month after starting to use levetiracetam. Dermatological exam and histopathological findings were consistent with bullous pemphigoid. To the best of our knowledge this is the first case of bullous pemphigoid in the literature associated with levetiracetam use. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.3109/15569527.2012.725444
dc.identifier.endpage 178 en_US
dc.identifier.issn 1556-9527
dc.identifier.issue 2 en_US
dc.identifier.pmid 23030621
dc.identifier.scopus 2-s2.0-84869396339
dc.identifier.scopusquality Q3
dc.identifier.startpage 176 en_US
dc.identifier.uri https://doi.org/10.3109/15569527.2012.725444
dc.identifier.uri https://hdl.handle.net/20.500.14720/16109
dc.identifier.volume 32 en_US
dc.identifier.wos WOS:000311234500018
dc.identifier.wosquality Q4
dc.language.iso en en_US
dc.publisher informa Healthcare en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Bullous Pemphigoid en_US
dc.subject Drug Eruption en_US
dc.subject Levetiracetam en_US
dc.title A Case of Levetiracetam Induced Bullous Pemphigoid en_US
dc.type Article en_US

Files